Svenja Philipp

Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease

Sajad Moshkelgosha, Hedda Luise Verhasselt, Giulia Masetti et al. · Microbiome · 2021 · 89 citations · Full text

Life Sciences, Endocrinology, Microbiology +17

Prolactin-dependent activation of a tyrosine phosphorylated DNA binding factor in mouse mammary epithelial cells.

Thomas Welte, Katja Garimorth, Svenja Philipp et al. · Molecular Endocrinology · 1994 · 80 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease

Anne Gulbins, Mareike Horstmann, Anke Daser et al. · Frontiers in Endocrinology · 2023 · 49 citations · Full text

Medicine, Endocrinology, Pharmacology +14

Predicting the Relapse of Hyperthyroidism in Treated Graves’ Disease with Orbitopathy by Serial Measurements of TSH-Receptor Autoantibodies

Mareile Stöhr, Michael Oeverhaus, Simon D. Lytton et al. · Hormone and Metabolic Research · 2021 · 28 citations · Full text

Medicine, Endocrinology, Immunology +13

Predicting the Course of Graves’ Orbitopathy Using Serially Measured TSH-Receptor Autoantibodies by Automated Binding Immunoassays and the Functional Bioassay

Svenja Philipp, Anja Eckstein, Mareile Stöhr et al. · Hormone and Metabolic Research · 2021 · 25 citations · Full text

Life Sciences, Endocrinology, Internal Medicine +17